An Open-label Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of SKP-0141 for the Treatment and Prophylaxis in Severe Hemophilia a Patients
Clinical trial NCT06738901 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06738901
- Sponsor
- SK Plasma Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-31
- Primary completion
- 2026-07-31
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.